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Abstract
In November 2008, BMC Medicine passed the landmark of its first 5 years of publishing. When we
launched the journal with the aim of publishing high quality research of general interest and special
importance, we had no idea what the future would bring. To mark the occasion of our 5th
anniversary, we consider the achievements of the last 5 years and discuss our plans for the future.
Editorial
BMC Medicine, the flagship medical journal of the BMC
series, recently celebrated its 5th anniversary. Over the last
five years, the journal has developed substantially and has
even been accepted for citation tracking by ISI within its
first three years of publishing. As a result we are eagerly
anticipating the journal's first official Impact Factor, due
in June 2009.
When BMC Medicine launched in November 2003, open
access publishing was still a fairly novel concept. The last
five years have seen open access evolve from what many
considered to be a fringe movement to a widely accepted
and sustainable business model for the publishing indus-
try. This is particularly underlined by the recent acquisi-
tion of BioMed Central, the publisher of BMC Medicine,
by Springer Science & Business Media, the world's second
largest publisher of scientific, technical and medical jour-
nals.
BMC Medicine aims to publish articles of outstanding
quality, broad interest and special importance. In 2003 we
had no idea of what the future would bring-we launched
BMC Medicine with the highest of expectations and the
support of an internationally renowned Editorial Board,
but would medical researchers accept such an open access
journal?
Now, in celebration of our anniversary and in anticipa-
tion of our first official Impact Factor in June 2009, we
reflect on the successes so far. As with all journals, the first
measure of BMC Medicine's success is in the quality of its
published articles. The systematic review of the incidence
of schizophrenia, by John McGrath and colleagues [1],
has been cited an amazing 92 times at the time of writing,
and the second [2] and third [3] most cited articles have
52 and 40 citations respectively. BMC Medicine articles
have been cited in such journals as The Lancet, New Eng-
land Journal of Medicine, JAMA and BMJ, together with a
whole range of other top tier general and subject-specific
publications.
Another measure of quality is circulation – as BMC Medi-
cine is an open access journal without subscription barri-
ers or print editions, we use article accesses in place of
circulation numbers. Most original research articles pub-
lished in BMC Medicine become highly accessed [4] soon
after publication, and the number of accesses over time
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can be staggering. For instance, the systematic review and
meta-analysis of the incidence of contrast-induced neph-
ropathy, by Sean Bagshaw and William Ghali [5], has
been accessed almost 55,000 times from the BMC Medi-
cine  website alone. Moreover, an article by Chris
McManus and colleagues [6] published this year has
achieved over 10,000 article accesses in under 12 months.
These articles are also freely available through a number
of other sites, such as PubMed Central, so the actual num-
bers of accesses for each article are much higher.
We could not have achieved our strong readership and
rapid development without the help and support of our
international Editorial Board. Members of our Editorial
Board have contributed their time as authors, referees,
and advisors. We are indebted to them for all of these con-
tributions, as well as the effort they put into raising the
profile of the journal within their respective fields. Finally,
we would not be where we are today without the signifi-
cant contributions of our authors and reviewers: we look
forward to your continued support as we move forward.
While the editorial staff are delighted with the journal's
progress so far, we continue to strive to improve the qual-
ity of the content of BMC Medicine, our service to authors,
and the position of the journal within the medical com-
munity. In line with these ambitions, we have substantial
plans for development in the near-term and long-term
future. We are expanding our portfolio of articles to
include commissioned review and minireview articles, as
well as commentaries on articles and subjects of interest to
our readership. Other article types will follow in due
course. In addition we are expanding the Editorial Board
for BMC Medicine. 2009 will also see the Editorial Team
attending conferences and meetings – we hope to meet
with you soon!
We look forward to our next five years of publishing; in
particular to receiving our first official Impact Factor,
expanding the Editorial Board and publishing new con-
tent of interest to our readers. Of course, as ever, we antic-
ipate publishing more research of excellent quality that
changes medical research and clinical practice, together
with thought-provoking and clinically relevant reviews to
highlight recent developments in a given field.
If you are interested in contributing to BMC Medicine or
have suggestions for how to improve the journal, please
submit your article via the journal website http://
www.biomedcentral.com/bmcmed or contact the Edito-
rial office with any queries editorial@biomedcentral.com.
Our aim is to make BMC Medicine a leading general med-
ical journal, and we look forward to working with you to
accomplish this goal.
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